Product Pathways
BCP0014 ADL5859
ADL-5859 is an agonist agents that selectively stimulate the δ-opioid receptor with potential application in a wide range of inflammatory, neuropathic and acute pain conditions.
BCP0150 A769662
A-769662 is a potent, reversible AMPK activator with EC50 of 0.8 μM and inhibits fatty acid synthesis with IC50 of 3.2 μM.
BCP0522 SB 612111
Selective NOP receptor antagonist (Ki: 0.33 nM).
BCP0523 SNC 80
A highly selective and potent non-peptide δ-opioid agonist, 2000-fold selective over μ-opioid receptors.
BCP000653 TMCB
Dual-kinase inhibitor; inhibits both casein kinase 2 (CK2) and extracellular-signal-regulated kinase 8 (ERK8) (IC50 = 0.50 ?M for both CK2 and ERK8).
BCP000661 MCOPPB trihydrochloride
MCOPPB trihydrochloride is a trihydrochloride form of MCOPPB that is a new nonpeptide nociceptin/orphanin FQ peptide (NOP)-receptor agonist with a pKi of 10.07 0.01 for the human NOP receptor.
BCP000722 CX4945
Serine-threonine protein kinase and PARP modulator
BCP000876 JTC-801
BCP000921 BAN ORL 24 HCl
Highly potent and selective NOP receptor antagonist (IC50: 0.27 nM); more than 2500 fold selective over other opioid receptors
BCP000945 H89 dihydrochloride
第一页 1 2 最后页 
Only for research purpose , not for human consumption Copyright©2012 ShangHai Biochempartner Co.,Ltd.